ALEXANDRIA, Va., Feb. 17 -- United States Patent no. 12,551,553, issued on Feb. 17, was assigned to GlaxoSmithKline Biologicals SA (Rixensart, Belgium).
"Methods for manufacturing an adjuvant" was invented by Pol Harvengt (Rixensart, Belgium), Philippe Jehoulot (Rixensart, Belgium), Loic Le Gourrierec (Rixensart, Belgium), Demostene Sifakakis (Rixensart, Belgium) and Laurent Strodiot (Rixensart, Belgium).
According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to compositions and methods for manufacturing an adjuvant comprising an aminoalkyl glucosaminide phosphate compound or glucopyranosyl lipid adjuvant using a microfluidic device and to related aspects."
The patent was filed on Nov. 2...